- Home
- ZBIO vs IMMR Comparison
ZBIO vs IMMR Comparison
Compare ZBIO & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- IMMR
- Stock Information
- Founded
- ZBIO 2019
- IMMR 1993
- Country
- ZBIO United States
- IMMR United States
- Employees
- ZBIO N/A
- IMMR N/A
- Industry
- ZBIO
- IMMR Computer peripheral equipment
- Sector
- ZBIO
- IMMR Technology
- Exchange
- ZBIO NYSE
- IMMR Nasdaq
- Market Cap
- ZBIO 339.3M
- IMMR 272.7M
- IPO Year
- ZBIO 2024
- IMMR 1999
- Fundamental
- Price
- ZBIO $8.40
- IMMR $8.55
- Analyst Decision
- ZBIO Strong Buy
- IMMR Strong Buy
- Analyst Count
- ZBIO 5
- IMMR 1
- Target Price
- ZBIO $31.75
- IMMR $13.50
- AVG Volume (30 Days)
- ZBIO 371.9K
- IMMR 826.9K
- Earning Date
- ZBIO 02-16-2025
- IMMR 03-06-2025
- Dividend Yield
- ZBIO N/A
- IMMR 1.57%
- EPS Growth
- ZBIO N/A
- IMMR 57.07
- EPS
- ZBIO N/A
- IMMR 2.04
- Revenue
- ZBIO N/A
- IMMR $163,133,000.00
- Revenue This Year
- ZBIO N/A
- IMMR $988.71
- Revenue Next Year
- ZBIO N/A
- IMMR $288.32
- P/E Ratio
- ZBIO N/A
- IMMR $4.22
- Revenue Growth
- ZBIO N/A
- IMMR 338.21
- 52 Week Low
- ZBIO $7.50
- IMMR $6.54
- 52 Week High
- ZBIO $26.25
- IMMR $13.94
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- IMMR 46.35
- Support Level
- ZBIO N/A
- IMMR $8.50
- Resistance Level
- ZBIO N/A
- IMMR $8.87
- Average True Range (ATR)
- ZBIO 0.00
- IMMR 0.39
- MACD
- ZBIO 0.00
- IMMR -0.02
- Stochastic Oscillator
- ZBIO 0.00
- IMMR 45.26
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.